CrossBridge Bio

About CrossBridge Bio

CrossBridge Bio is an innovative company focused on revolutionizing cancer therapeutics through its advanced Antibody-Drug Conjugate (ADC) technology platform. The company aims to overcome the limitations of current ADCs by delivering safer and more effective treatments for patients using stable dual linker payload technology.

Products & Services

EGCit (GluGlyCit) Enzymatically Cleavable Linker:A proprietary linker with enhanced stability over traditional ValCit linkers, increased hydrophilicity, and the ability to curb premature payload release while ensuring swift release in targeted cancer cells.

Enzymatic Conjugation of Branched Linkers:Utilizes microbial Transglutaminase (mTG) to conjugate branched linkers to human IgG1, enabling uniform ADCs with precise control over Drug-to-Antibody Ratio (DAR) and supporting dual-payload ADCs.

Synergistic Antibody-Payload Pairings:An integrated platform that combines diverse antibodies and payloads to create first-in-class and best-in-class ADC products with optimal molecular properties and safety profiles.

Specialties

Antibody-Drug Conjugates (ADCs) Cancer Therapeutics Stable Dual Linker Payload Technology Enzymatic Conjugation Drug-to-Antibody Ratio (DAR) Control

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2025-11-20 FD: 2025-11-20	1 investors
2	RT: Seed T: - FT: Seed	A: 10000000 MR: - FA: 10 million FAN: 10000000	D: 2024-11-04 FD: 2024-11-04	6 investors

Grant Latest

2025-11-20

$15.0M

1 investor (Pro only)

Seed 2024-11-04

$10.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Torres

Co-Founder & Chief Executive Officer

A

Abhishake Chhibber

Chief Operating Officer

D

Daniel Pereira

Chief Scientific Officer

M

Morris Rosenberg

Acting Chief Technology Officer

Z

Zhiqiang An

Co-Founder & SAB

K

Kyoji Tsuchikama

Co-Founder & SAB

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

CrossBridge Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised